These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12956429)

  • 1. Integrating B cell homeostasis and selection with BLyS.
    Harless Smith S; Cancro MP
    Arch Immunol Ther Exp (Warsz); 2003; 51(4):209-18. PubMed ID: 12956429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral B-cell maturation: the intersection of selection and homeostasis.
    Cancro MP
    Immunol Rev; 2004 Feb; 197():89-101. PubMed ID: 14962189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BLyS: the pivotal determinant of peripheral B cell selection and lifespan.
    Harless Smith S; Cancro MP
    Curr Pharm Des; 2003; 9(23):1833-47. PubMed ID: 12871188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competition for BLyS-mediated signaling through Bcmd/BR3 regulates peripheral B lymphocyte numbers.
    Harless SM; Lentz VM; Sah AP; Hsu BL; Clise-Dwyer K; Hilbert DM; Hayes CE; Cancro MP
    Curr Biol; 2001 Dec; 11(24):1986-9. PubMed ID: 11747827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral B cell selection and homeostasis.
    Cancro MP; Smith SH
    Immunol Res; 2003; 27(2-3):141-8. PubMed ID: 12857963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting edge: B cell receptor signals regulate BLyS receptor levels in mature B cells and their immediate progenitors.
    Smith SH; Cancro MP
    J Immunol; 2003 Jun; 170(12):5820-3. PubMed ID: 12794106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency.
    Yan M; Brady JR; Chan B; Lee WP; Hsu B; Harless S; Cancro M; Grewal IS; Dixit VM
    Curr Biol; 2001 Oct; 11(19):1547-52. PubMed ID: 11591325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Space, selection, and surveillance: setting boundaries with BLyS.
    Miller JP; Stadanlick JE; Cancro MP
    J Immunol; 2006 Jun; 176(11):6405-10. PubMed ID: 16709796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of BLyS/BLyS receptors in anti-chromatin B cell regulation.
    Hondowicz BD; Alexander ST; Quinn WJ; Pagán AJ; Metzgar MH; Cancro MP; Erikson J
    Int Immunol; 2007 Apr; 19(4):465-75. PubMed ID: 17369193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B lymphocyte stimulator (BLyS): a therapeutic trichotomy for the treatment of B lymphocyte diseases.
    Nardelli B; Moore PA; Li Y; Hilbert DM
    Leuk Lymphoma; 2002 Jul; 43(7):1367-73. PubMed ID: 12389615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell homeostasis requires complementary CD22 and BLyS/BR3 survival signals.
    Smith SH; Haas KM; Poe JC; Yanaba K; Ward CD; Migone TS; Tedder TF
    Int Immunol; 2010 Aug; 22(8):681-91. PubMed ID: 20513733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunology. Long live the mature B cell--a baffling mystery resolved.
    Waldschmidt TJ; Noelle RJ
    Science; 2001 Sep; 293(5537):2012-3. PubMed ID: 11557866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators.
    Hsu BL; Harless SM; Lindsley RC; Hilbert DM; Cancro MP
    J Immunol; 2002 Jun; 168(12):5993-6. PubMed ID: 12055205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen.
    Schneider P; Takatsuka H; Wilson A; Mackay F; Tardivel A; Lens S; Cachero TG; Finke D; Beermann F; Tschopp J
    J Exp Med; 2001 Dec; 194(11):1691-7. PubMed ID: 11733583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BLyS family of ligands and receptors: an archetype for niche-specific homeostatic regulation.
    Cancro MP
    Immunol Rev; 2004 Dec; 202():237-49. PubMed ID: 15546397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator.
    Moore PA; Belvedere O; Orr A; Pieri K; LaFleur DW; Feng P; Soppet D; Charters M; Gentz R; Parmelee D; Li Y; Galperina O; Giri J; Roschke V; Nardelli B; Carrell J; Sosnovtseva S; Greenfield W; Ruben SM; Olsen HS; Fikes J; Hilbert DM
    Science; 1999 Jul; 285(5425):260-3. PubMed ID: 10398604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human B lymphocyte malignancies: exploitation of BLyS and APRIL and their receptors.
    Jelinek DF; Darce JR
    Curr Dir Autoimmun; 2005; 8():266-88. PubMed ID: 15564725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys.
    Vugmeyster Y; Seshasayee D; Chang W; Storn A; Howell K; Sa S; Nelson T; Martin F; Grewal I; Gilkerson E; Wu B; Thompson J; Ehrenfels BN; Ren S; Song A; Gelzleichter TR; Danilenko DM
    Am J Pathol; 2006 Feb; 168(2):476-89. PubMed ID: 16436662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. To B or not to B: TNF family signaling in lymphocytes.
    Siegel RM; Lenardo MJ
    Nat Immunol; 2001 Jul; 2(7):577-8. PubMed ID: 11429537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BLyS--an essential survival factor for B cells: basic biology, links to pathology and therapeutic target.
    Baker KP
    Autoimmun Rev; 2004 Jul; 3(5):368-75. PubMed ID: 15288003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.